Close Menu

NEW YORK – The National Institutes of Health said this week that the Accelerating Medicines Partnership (AMP) program for Parkinson's disease has launched a data portal to provide researchers with de-identified information collected from 4,298 Parkinson's patients and healthy controls. The portal can be used to develop therapies for the disease, study complex data sets, and perform genome-wide analyses at a large scale.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

The New York Times reports that a new viral variant of concern has been identified in New York City.

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.